Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention

Maintenance treatment with an inhaled corticosteroid (ICS) and a long-acting β2-agonist (LABA) is recommended for patients whose asthma is not controlled with a low-to-moderate dose of ICS alone; a separate reliever medication is used on an as-needed basis. The Gaining Optimal Asthma ControL (GOAL) study demonstrated that salmeterol/fluticasone maintenance treatment can improve asthma control and reduce future risk compared with fluticasone alone, although the dose escalation design of this study meant that most patients treated with salmeterol/fluticasone were receiving the highest dose of ICS at the end of the study.

Source: Respiratory Medicine CME - November 5, 2015 Category: Respiratory Medicine Authors: René Aalbers, Claus Vogelmeier, Piotr Kuna Tags: Review article Source Type: research